Acclinate
PrivateLast Round
Series A
May 7, 2024
Est. Valuation
$20M
Total Funding Raised
$10.77M
Momentum Score
25 /100
Company Overview
Acclinate is a digital health company that offers a platform leveraging machine learning and predictive analytics to enhance representation and diversity in genomic research and clinical trials by automating participant identification, education, engagement, and retention.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Patient Engagement, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Acclinate Comps
Public and private peers based on sector, stage, and business model.
Acclinate Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 7, 2024 | ||||
| Seed | Nov 1, 2022 | ||||
| Grant | Oct 14, 2022 | ||||
| Grant | Sep 21, 2021 | ||||
| Accelerator | Feb 5, 2021 | ||||
Pre Seed | Sep 15, 2020 |
Key People
Founding team and executive leadership
Acclinate Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Overline | Seed |
| Latimer Ventures | Series A |
| Techstars | Accelerator, Seed |
| Google for Startups Black Founders Fund | Grant |
| Alabama Launchpad | Grant |
| Black Star Fund | Seed |
| Johnson & Johnson Innovation - JJDC, Inc. | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 16, 2026
Co-Founder Tiffany Whitlow named to Inc.'s 2026 Female Founders 500 list.
- Mar 16, 2026
NOWINCLUDED Unfiltered podcast aims to expand community footprint.
Acclinate Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Acclinate's valuation, stock price, and market status.
